Current Issue

Presented by Jason Creasey, Managing Director at Maven E&L Ltd and Dries Cardoen, Team Leader of Study Directors Inhalation/topical/transdermal products at Nelson Laboratories, LLC
22nd March 2021

Creation of a real time process data framework with external manufacturer to enhance process performance, technology transfer success and drive cost savings

Presented by Olav Lyngberg, Advanced Analytics, Modeling & Process Analytical Technology Leader at The Janssen Pharmaceutical Companies of Johnson & Johnson
08th February 2023

An Interview with Dr Günter Jagschies, of GE BioProcess teams on What are the main opportunities and challenges in the rapidly evolving Asian biopharma markets?

Presented by An Interview with Dr. Günter Jagschies, business advisor for the GE BioProcess teams
18th June 2018

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos

Current Issue

Application of Quality Risk Management to Process Validation

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Amsphere A3

Featured Articles

Beyond Quality: PAT as a Catalyst for Carbon Reduction in Pharma

Changing Column Packing from an Art into a Science

Endotoxin Control Strategies for Parenteral Drug Product Manufacturing

Novel Synthetic Adsorptive Depth Filter Media for CHO Harvest Clarification

Headline News

Teva’s Weltruza becomes first once monthly subcutaneous olanzapine injection to win FDA approval for adults with schizophrenia

Viatris agrees to acquire Pacira BioSciences for $1.65 billion to add Exparel and Zilretta

Regeneron’s Pasatru shows no new bone lesions in adult FOP patients between weeks 56 and 84 of OPTIMA

Upcoming Webinars

Past Webinars

ICH Q3E Guidelines and Its Implications

Creation of a real time process data framework with external manufacturer to enhance process performance, technology transfer success and drive cost savings

An Interview with Dr Günter Jagschies, of GE BioProcess teams on What are the main opportunities and challenges in the rapidly evolving Asian biopharma markets?

Featured Companies

Featured Video

Technical Papers

Push-Button Simplicity: Automatic Fermentation with the BioFlo® 120 Auto Culture Mode

Column Packing Protocol for Amsphere A3

Strategy Emerging Markets for Risk Mitigation

Featured Products

Decrease Cleaning Validation Time and Resources

AdvantaPure

Amsphere™ A3 Protein A Resin – JSR Life Sciences